Cerevel Therapeutics Holdings, Inc.

FARALLON CAPITAL MANAGEMENT LLC

Report date

6/30/2024

Quarter

2024 Q2

Filed

8/14/2024

Shares

1,190,000

Value ($000)

48,659

Weight

0.3%

2023 Q4 - 2024 Q2 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q2	8/14/2024	48,659	0.3%	1,190,000	6/30/2024
2023 Q4	2/14/2024	24,054	0.2%	567,321	12/31/2023